Objectives: To measure respiratory functions of ambulatory patients with multiple sclerosis and compare the results with expected values from healthy general population data. Further, to study the correlation of respiratory function impairment with the multiple sclerosis-induced disability level.
Subjects: Thirty-eight patients with definite diagnosis of multiple sclerosis from the multiple sclerosis outpatient clinic.
Methods: The Expanded Disability Status Scale (EDSS) scores (mean 4.34±1.39) were evaluated to measure disability level. Respiratory functions tested in the laboratory included spirometric (FVC, FEV1, FEV1/FVC), maximal inspiratory (MIP) and expiratory (MEP) mouth pressure measurements. Patients were clinically assessed using a pulmonary dysfunction index (PDI) and dyspnoea index; various breathing features were also recorded.
Results: With respect to expected values from healthy general population, important decreases were found in mouth pressures with MIP (77%±23%, p ≃ 0) and MEP (60%±13%, p ≃ 0) while spirometric measures were significantly but less affected (FVC 94%±12%, p < 0.01, FEV1 91%±16%, p < 0.001). FEV1/FVC ratios were normal. Notable increases in PDI (5.58±0.68, p ≃ 0) and dyspnoea index (0.32±0.47, p ≃ 0) were observed. Significant relationships (p < 0.01) between respiratory function impairment and the multiple sclerosis disability level could be detected for FVC, MEP and PDI.
Conclusions: Multiple sclerosis clearly impairs respiratory functions; maximal mouth pressures are more severely reduced. This impairment increases with multiple sclerosis-induced disability level but is found to be independent from duration of disease.
Get full access to this article
View all access options for this article.
References
1.
1 Matthews WB, Compston A Allen IV, Martyn CN. McAlpine's multiple sclerosis, second edition. Edinburgh: Churchill Livingstone, 1991.
2.
2 Miller JR. Multiple sclerosis. In: Rowland LP ed. Merrit's neurology, tenth edition. Philadelphia: Lippincott Williams and Wilkins, 2000: 773–792.
7 Criner GJ, Kelsen SG. Effects of neuromuscular disease on ventilation. In: Fishman AP ed. Fishman's pulmonary disease and disorders, third edition. New York: McGraw-Hill, 1998: 561–585.
8.
8 Gosselink R, Kovacs L, Ketelaer P, Carton H, Decramer M. Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil2000; 81: 747–751.
9.
9 Smeltzer SC, Utell MJ, Rudick RA, Herndon RM. Pulmonary function and dysfunction in multiple sclerosis. Arch Neurol1988; 45: 1245–1249.
10.
10 Buyse B, Demedts M, Meekers J, Vandegaer L, Rochette F, Kerkhofs L. Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients. Eur Respir J1997; 10: 139–145.
11.
11 Foglio K, Clini E, Facchetti D et al. Respiratory muscle function and exercise capacity in multiple sclerosis. Eur Respir1994; 7:23–28.
12.
12 Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
13.
13 Parker S, Middleton PG. Assessment. In: Webber BA, Pryor JA eds. Physiotherapy for respiratory and cardiac problems. London: Churchill Livingstone, 1995: 3–22.
14.
14 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology1983; 33: 1444–1452.
15.
15 Miller A. Prediction equations and ‘normal values’ for pulmonary function tests. In: Miller A ed. Pulmonary function tests. Orlando: Grune and Stratton, 1987: 125–148.
16.
16 Lopata M. Assessment of lung mechanics. In: Cherniack NS, Altose MD, Homma I eds. Rehabilitation of the patient with respiratory disease. New York: McGraw-Hill, 1999: 205–215.
18 Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax1984; 39: 535–538.
19.
19 Wetzel J, Lunsford BR, Peterson MJ, Alvarez SE. Respiratory rehabilitation of the patient with a spinal cord injury. In: Irwin S, Tecklin JS eds. Cardiopulmonary physical therapy. St. Louis: CV Mosby, 1985: 395–420.
20.
20 Smeltzer SC, Lavietes MH, Troiano R, Cook SD. Testing of an index of pulmonary dysfunction in multiple sclerosis. Nurs Res1989; 38: 370–374.
21.
21 Mahler AD, Weinberg HD, Wells KC, Feinstein RA. The measurement of dyspnoea. Chest, 1984; 85: 751–758.
22.
22 Hough A. Physiotherapy in respiratory care. A problem solving approach. London: Chapman and Hall, 1993: 21-21.
23.
23 Smeltzer SC, Skurnick JH, Troiano R, Cook SD, Duran W, Lavietes MH. Respiratory function in multiple sclerosis. Utility of clinical assessment of respiratory muscle function. Chest1992; 101: 479–484.
24.
24 Klaveren R, Buyse T, De Gaer LV, Meekers J, Rochette F, Demedts M. Micturitional disturbances are associated with impaired breathing control in multiple sclerosis. Chest1999; 116: 1539–1545.
25.
25 Vincken W, Elleker M, Cosio MG. Determinants of respiratory muscle weakness in stable chronic neuromuscular disorders. Am J Med1987; 82:53–58.
26.
26 Tantucci C, Massucci M, Piperno R, Betti L, Grassi V, Sorbini CA. Control of breathing and respiratory muscle strength in patients with multiple sclerosis. Chest1994; 105: 1163–1170.
27.
27 Smeltzer SC, Lavietes MH. Reliability of maximal respiratory pressures in multiple sclerosis. Chest1999; 115: 1546–1552.
